ATE328601T1 - Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien - Google Patents

Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien

Info

Publication number
ATE328601T1
ATE328601T1 AT00991231T AT00991231T ATE328601T1 AT E328601 T1 ATE328601 T1 AT E328601T1 AT 00991231 T AT00991231 T AT 00991231T AT 00991231 T AT00991231 T AT 00991231T AT E328601 T1 ATE328601 T1 AT E328601T1
Authority
AT
Austria
Prior art keywords
sleep
cncm
lactic acid
acid bacteria
promoting effect
Prior art date
Application number
AT00991231T
Other languages
English (en)
Inventor
James M Krueger
Michael J Pabst
Chantal Cayuela
Marie-Christine Degivry
Donna Hartley
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Application granted granted Critical
Publication of ATE328601T1 publication Critical patent/ATE328601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00991231T 1999-12-20 2000-12-20 Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien ATE328601T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/466,768 US6444203B2 (en) 1999-12-20 1999-12-20 Administering bacteria to improve sleep

Publications (1)

Publication Number Publication Date
ATE328601T1 true ATE328601T1 (de) 2006-06-15

Family

ID=23853027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991231T ATE328601T1 (de) 1999-12-20 2000-12-20 Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien

Country Status (19)

Country Link
US (1) US6444203B2 (de)
EP (1) EP1251860B1 (de)
JP (1) JP4527922B2 (de)
AT (1) ATE328601T1 (de)
AU (1) AU3161801A (de)
BR (1) BR0016523A (de)
CA (1) CA2394802A1 (de)
CZ (1) CZ20022483A3 (de)
DE (1) DE60028613T2 (de)
DK (1) DK1251860T3 (de)
ES (1) ES2266023T3 (de)
HU (1) HUP0300025A3 (de)
MX (1) MXPA02006116A (de)
PL (1) PL202465B1 (de)
PT (1) PT1251860E (de)
RU (1) RU2262943C2 (de)
SK (1) SK10662002A3 (de)
WO (1) WO2001045722A1 (de)
ZA (1) ZA200204974B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
CN1960739B (zh) * 2004-03-31 2010-06-16 卡尔皮斯株式会社 改善内源性褪黑素分泌规律用功能食品和改善昼夜节律用功能食品
US20150147298A1 (en) * 2006-07-24 2015-05-28 CortControl, Inc. Sleep enhancement with cortisol reduction medical food
EP2110028A1 (de) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum und hippocampale BDNF-Expression
RU2642301C9 (ru) * 2008-11-03 2018-06-27 Нестек С.А. Пробиотический бактериальный штамм для получения питательной композиции, улучшающей характер сна
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
FR2938552B1 (fr) 2008-11-19 2010-12-03 Gervais Danone Sa Souche hypocholesterolemiante de lactobacillus delbrueckii
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
JP2016505239A (ja) * 2012-10-25 2016-02-25 コンパニ・ジェルベ・ダノン ヘリコバクター・ピロリ感染症の治療用のストレプトコッカス・サーモフィルス株
CN106132424A (zh) * 2014-03-25 2016-11-16 株式会社益力多本社 睡眠质量改善剂
JP6127169B2 (ja) * 2016-02-15 2017-05-10 三基商事株式会社 睡眠改善剤
JP7154473B2 (ja) 2017-05-31 2022-10-18 学校法人順天堂 疲労回復用および／または疲労蓄積予防用組成物
US20200323227A1 (en) * 2017-12-19 2020-10-15 Compagnie Gervais Danone Fermented dairy compositions and methods of preparing the same
CN111297915B (zh) * 2019-04-12 2021-11-23 首都医科大学附属北京友谊医院 治疗帕金森病快速眼动期睡眠行为障碍的益生菌组合物、制剂及用途
EP4009797A1 (de) * 2019-08-09 2022-06-15 Compagnie Gervais Danone Fermentierte zusammensetzungen und verfahren zu ihrer herstellung
US20220322689A1 (en) * 2019-08-09 2022-10-13 Compagnie Gervais Danone Fermented plant-based probiotic compositions and processes of preparing the same
JP6873291B1 (ja) 2020-02-05 2021-05-19 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
CN113854457A (zh) * 2021-09-18 2021-12-31 山东绿丰生态农业股份有限公司 一种助睡眠促消化樱桃酵素固体饮品及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110476A (en) * 1977-01-10 1978-08-29 Johnson/Rhodes Cultured Foods, Inc. Preparation of liquid and frozen yogurt products
CH654330A5 (en) 1980-01-31 1986-02-14 Sp Kt Bjuro Dezi Process for the preparation of a biological product for stimulating vitality of humans and animals
US4624853A (en) * 1983-02-07 1986-11-25 S. C. Johnson & Son, Inc. Instant yogurt food product
US4698330A (en) 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
DE3624010A1 (de) 1986-07-16 1988-01-28 Sen Wilhelm Kanne Arznei- bzw. heilmittel zur behandlung des ganzheitlichen menschlichen organismus
US4837036A (en) * 1987-05-22 1989-06-06 The Pro-Mark Companies, Inc. Low fat thin-bodied yogurt product and method
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
CN1114217A (zh) 1994-06-23 1996-01-03 南京肉类联合加工厂 生物活性口服液
ES2137292T3 (es) * 1994-06-29 1999-12-16 Nestle Sa Producto alimenticio fermentado para animales.
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
WO1996020607A1 (fr) * 1995-01-02 1996-07-11 Compagnie Gervais Danone Ferment lactique, et son utilisation pour la preparation de produits anti-diarrheiques
FR2771600B1 (fr) * 1997-11-28 2000-06-09 Gervais Danone Co Preparation de produits alimentaires par fermentation d'un melange de jus de soja et d'hydrolysat cerealier par streptococcus thermophilus
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Also Published As

Publication number Publication date
JP2003517828A (ja) 2003-06-03
MXPA02006116A (es) 2004-08-23
US6444203B2 (en) 2002-09-03
US20010051152A1 (en) 2001-12-13
EP1251860B1 (de) 2006-06-07
CA2394802A1 (en) 2001-06-28
ZA200204974B (en) 2005-10-31
RU2262943C2 (ru) 2005-10-27
RU2002119413A (ru) 2004-02-27
PT1251860E (pt) 2006-10-31
ES2266023T3 (es) 2007-03-01
AU3161801A (en) 2001-07-03
DK1251860T3 (da) 2006-10-16
PL356459A1 (en) 2004-06-28
EP1251860A1 (de) 2002-10-30
DE60028613T2 (de) 2007-05-31
WO2001045722A9 (en) 2002-09-12
HUP0300025A2 (en) 2003-05-28
SK10662002A3 (sk) 2005-06-02
HUP0300025A3 (en) 2004-12-28
JP4527922B2 (ja) 2010-08-18
PL202465B1 (pl) 2009-06-30
WO2001045722A1 (en) 2001-06-28
BR0016523A (pt) 2002-09-24
DE60028613D1 (de) 2006-07-20
CZ20022483A3 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
ATE328601T1 (de) Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
Blum et al. Adhesion studies for probiotics: need for validation and refinement
GB2338245A (en) Immunity enhancing lactic acid bacteria
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
GB0124580D0 (en) New composition
NO932408D0 (no) Melkesyrebakterier
WO1999061627A3 (fr) Souches mutantes de lactobacillus bulgaricus depourvues d'activite beta-galactosidase
DK0794707T3 (da) Mælkesyreferment og anvendelse deraf til fremstilling af antidiarréiske produkter
DE69514446D1 (de) Hemmung von Clostridia mit Milchsäurebakterien
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
De Petrino et al. Influence of the oral administration of different lactic acid bacteria on intestinal microflora and iga‐secreting cells in mice treated with ampicillin
RU92001155A (ru) Способ получения ферментированного продукта из пахты
KR960034401A (ko) 프로바이오틱에 적합한 비피더스균 및 그의 분말 비피더스균 제제
Broadbent et al. Biotechnology of dairy starter cultures
RU98111070A (ru) Штаммы молочнокислых бактерий и способ улучшения кишечной флоры
MD1853G2 (ro) Preparat microbian eubiotic pentru profilaxia şi tratamentul disbacteriozei intestinale
GEP20033132B (en) Bacteriological Preparations
RU99124523A (ru) Способ комплексного лечения больных нейродермитом
ES2155783A1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
YU40192A (sh) Novi autohtoni soj lactobacillus delbrueckii subsp. bulgaricus ob

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1251860

Country of ref document: EP